{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:01:16Z","timestamp":1780124476084,"version":"3.54.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07010-5","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:42:33Z","timestamp":1777624953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of fluoroquinolone prophylaxis during induction phase in children with acute lymphoblastic leukemia: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"185","author":[{"given":"Maria Clara","family":"Landivar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Hartmann Rost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Carvalho Kilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alejandra","family":"Torres Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Glenda","family":"Santarosa Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"7010_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1525751","author":"L Wang","year":"2025","unstructured":"Wang L, Yao X, Yang L (2025) Global, regional, and national burden of children and adolescents with acute lymphoblastic leukemia from 1990 to 2021: a systematic analysis for the global burden of disease study 2021. Front Public Health. https:\/\/doi.org\/10.3389\/fpubh.2025.1525751","journal-title":"Front Public Health"},{"key":"7010_CR2","doi-asserted-by":"publisher","unstructured":"Wali R, Anjum S, Amjad A, Shaheen N & Khan S (2021) Frequency of infectious mortality at the end of induction chemotherapy in acute lymphoblastic leukemia andlymphoma patients: findings from a tertiary care cancer center. Cureus, 13. https:\/\/doi.org\/10.7759\/cureus.13208.","DOI":"10.7759\/cureus.13208"},{"issue":"7","key":"7010_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/blood-2014-03-560847","volume":"124","author":"D O\u2019Connor","year":"2014","unstructured":"O\u2019Connor D, Bate J, Wade R, Clack R, Dhir S, Hough R, Vora A, Goulden N, Samarasinghe S (2014) Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood 124(7):1056\u20131061. https:\/\/doi.org\/10.1182\/blood-2014-03-560847","journal-title":"Blood"},{"key":"7010_CR4","doi-asserted-by":"publisher","unstructured":"Nair A, Elballushi R, Joshi R, Anjanappa S, Akter M, Arif S & Rehman S (2023) Assessment of the prevalence of infections in pediatric patients with acute lymphoblastic leukemia. Cureus, 15. https:\/\/doi.org\/10.7759\/cureus.46837.","DOI":"10.7759\/cureus.46837"},{"issue":"1","key":"7010_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","volume":"76","author":"M Mikulska","year":"2018","unstructured":"Mikulska M, Averbuch D, Tissot F, Cordonnier C, Akova M, Calandra T, Ceppi M, Bruzzi P, Viscoli C (2018) Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines. J Infect 76(1):20\u201337. https:\/\/doi.org\/10.1016\/j.jinf.2017.10.009","journal-title":"J Infect"},{"key":"7010_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piae077","author":"E Vasileiadi","year":"2024","unstructured":"Vasileiadi E, Lloyd K, Fisher B, Hanisch B (2024) Fluoroquinolone prophylaxis in children with cancer: a pro\/con discussion. J Pediatric Infect Dis Soc. https:\/\/doi.org\/10.1093\/jpids\/piae077","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"11","key":"7010_CR7","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/cid\/cix644","volume":"65","author":"J Wolf","year":"2017","unstructured":"Wolf J, Tang L, Flynn PM, Pui C-H, Gaur AH, Sun Y, Inaba H, Stewart T, Hayden RT, Hakim H, Jeha S (2017) Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia. Clin Infect Dis 65(11):1790\u20131798. https:\/\/doi.org\/10.1093\/cid\/cix644","journal-title":"Clin Infect Dis"},{"issue":"2","key":"7010_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2023.102745","volume":"27","author":"MC Dufrayer","year":"2023","unstructured":"Dufrayer MC, Rechenmacher C, Meneses CF, Monteiro YMC, Carlesse FAMC, Motta F, Daudt LE, Michalowski MB (2023) Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil. Braz J Infect Dis 27(2). https:\/\/doi.org\/10.1016\/j.bjid.2023.102745","journal-title":"Braz J Infect Dis"},{"key":"7010_CR9","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2023.1606","volume":"17","author":"A Ejaz","year":"2023","unstructured":"Ejaz A, Belgaumi AF, Alam SE, Ashraf MS, Raza MR (2023) Effectiveness of levofloxacin in the induction of chemotherapy in high-risk acute lymphoblastic leukaemia in children in a developing country. ecancermedicalscience 17. https:\/\/doi.org\/10.3332\/ecancer.2023.1606","journal-title":"ecancermedicalscience"},{"issue":"10","key":"7010_CR10","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.47391\/JPMA.7383","volume":"73","author":"P Rehman","year":"2023","unstructured":"Rehman P, Shaukat Z, Saeed H, Raza A, Anjum S, Wali RM (2023) Prophylactic use of levofloxacin during induction of acute lymphoblastic leukaemia in children: experience from Pakistan. J Pak Med Assoc 73(10):2065\u20132068. https:\/\/doi.org\/10.47391\/JPMA.7383","journal-title":"J Pak Med Assoc"},{"issue":"2","key":"7010_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jpediatrinf.2024.02.006","volume":"10","author":"F Scharloo","year":"2024","unstructured":"Scharloo F et al (2024) Impact of ciprofloxacin prophylaxis on bloodstream infections in pediatric oncology patients: a retrospective cohort study. J Pediatr Infect Dis 10(2):123\u2013130. https:\/\/doi.org\/10.1016\/j.jpediatrinf.2024.02.006","journal-title":"J Pediatr Infect Dis"},{"issue":"3","key":"7010_CR12","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1097\/INF.0b013e3182793610","volume":"32","author":"K Laoprasopwattana","year":"2013","unstructured":"Laoprasopwattana K, Khwanna T, Suwankeeree P, Sujjanunt T, Tunyapanit W, Chelae S (2013) Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy. Pediatr Infect Dis J 32(3):e94\u2013e98. https:\/\/doi.org\/10.1097\/INF.0b013e3182793610","journal-title":"Pediatr Infect Dis J"},{"key":"7010_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JBM.S33906","volume":"4","author":"PH Widjajanto","year":"2013","unstructured":"Widjajanto PH, Sumadiono S, Cloos J, Purwanto I, Sutaryo S, Veerman AJP (2013) Randomized double-blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia. J Blood Med 4:1\u20139. https:\/\/doi.org\/10.2147\/JBM.S33906","journal-title":"J Blood Med"},{"key":"7010_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac594","author":"D Leardini","year":"2022","unstructured":"Leardini D, Muratore E, Abram N, Baccelli F, Belotti T, Prete A, Gori D, Masetti R (2022) Effectiveness of quinolone prophylaxis in pediatric acute leukemia and hematopoietic stem cell transplantation: a systematic review and meta-analysis. Open Forum Infect Dis. https:\/\/doi.org\/10.1093\/ofid\/ofac594","journal-title":"Open Forum Infect Dis"},{"key":"7010_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2023.03.003","author":"M Yang","year":"2023","unstructured":"Yang M, Lu X, Xin L, Luo J, Diao S, Jia Z, Cheng G, Zeng L, Zhang L (2023) Comparative effectiveness and safety of antibiotic prophylaxis during induction chemotherapy in children with acute leukaemia: a systematic review and meta-analysis.. J Hosp Infect. https:\/\/doi.org\/10.1016\/j.jhin.2023.03.003","journal-title":"J Hosp Infect"},{"key":"7010_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"1","key":"7010_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"7010_CR18","unstructured":"U.S. Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE) v5.0. Published July 22, 2025. Available at: https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v6.pdf"},{"key":"7010_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"7010_CR20","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Mathur MB, Elbers R, Hr\u00f3bjartsson A, McAleenan A, Reeves B, et al (2025) Risk of bias in non-randomized studies of interventions (ROBINS-I), version 2. ROBINS-I V2 development group.\u00a0https:\/\/doi.org\/10.1136\/bmj.i4919","DOI":"10.1136\/bmj.i4919"},{"issue":"1","key":"7010_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-020-01513-7","volume":"10","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT (2021) Risk-of-bias visualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Syst Rev 10(1):1\u201310. https:\/\/doi.org\/10.1186\/s13643-020-01513-7","journal-title":"Syst Rev"},{"issue":"7650","key":"7010_CR22","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924\u2013926. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD","journal-title":"BMJ"},{"issue":"4","key":"7010_CR23","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719\u2013748","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"7010_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1\u201348. https:\/\/doi.org\/10.18637\/jss.v036.i03","journal-title":"J Stat Softw"},{"issue":"12","key":"7010_CR25","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/sim.791","volume":"20","author":"J Hartung","year":"2001","unstructured":"Hartung J, Knapp G (2001) On tests of the overall treatment effect in meta-analysis with normally distributed responses. Stat Med 20(12):1771\u20131782. https:\/\/doi.org\/10.1002\/sim.791","journal-title":"Stat Med"},{"key":"7010_CR26","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ & Welch VA (Eds.) (2024)\u00a0Cochrane handbook for systematic reviews of interventions (Version 6.5, updated August 2024). Cochrane. Available from https:\/\/www.cochrane.org\/handbook"},{"key":"7010_CR27","unstructured":"R Core Team. (2024). R: a language and environment for statistical computing (Version 4.5.0) [Computer software]. R Foundation for Statistical Computing. https:\/\/www.R-project.org\/"},{"key":"7010_CR28","unstructured":"Consensus. (2025). Consensus search. https:\/\/consensus.app\/"},{"key":"7010_CR29","unstructured":"OpenAI. (2025). ChatGPT (versi\u00f3n GPT-5.2) [Large language model]. https:\/\/chat.openai.com\/"},{"issue":"2","key":"7010_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/annonc\/mdw557","volume":"28","author":"H Inaba","year":"2017","unstructured":"Inaba H, Pei D, Wolf J, Howard SC, Hayden RT, Go M, Varechtchouk O, Hahn T, Buaboonnam J, Metzger ML, Rubnitz JE, Ribeiro RC, Sandlund JT, Jeha S, Cheng C, Evans WE, Relling MV, Pui C-H (2017) Infection-related complications during treatment for childhood acute lymphoblastic leukemia. Ann Oncol 28(2):386\u2013392. https:\/\/doi.org\/10.1093\/annonc\/mdw557","journal-title":"Ann Oncol"},{"issue":"11","key":"7010_CR31","doi-asserted-by":"publisher","first-page":"e4627","DOI":"10.1093\/cid\/ciaa068","volume":"73","author":"I Stoma","year":"2021","unstructured":"Stoma I, Littmann ER, Peled JU, Giralt S, van den Brink MRM, Pamer EG, Taur Y (2021) Compositional flux within the intestinal microbiota and risk for bloodstream infection with gram-negative bacteria. Clin Infect Dis 73(11):e4627\u2013e4635. https:\/\/doi.org\/10.1093\/cid\/ciaa068","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7010_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/cid\/ciz1082","volume":"71","author":"T Lehrnbecher","year":"2020","unstructured":"Lehrnbecher T, Fisher BT, Phillips B, Alexander S, Ammann RA, Beauchemin M, Carlesse F, Castagnola E, Davis BL, Dupuis LL, Egan G, Groll AH, Haeusler GM, Santolaya M, Steinbach WJ, van de Wetering M, Wolf J, Cabral S, Robinson PD, Sung L (2020) Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation. Clin Infect Dis 71(1):226\u2013236. https:\/\/doi.org\/10.1093\/cid\/ciz1082","journal-title":"Clin Infect Dis"},{"issue":"4","key":"7010_CR33","first-page":"228","volume":"43","author":"AJ Lucas","year":"2018","unstructured":"Lucas AJ, Olin JL, Coleman MD (2018) Management and preventive measures for febrile neutropenia. P T 43(4):228\u2013232","journal-title":"P T"},{"key":"7010_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08853-0","author":"JL Nunn","year":"2024","unstructured":"Nunn JL, Ullman AJ, Takashima MD, Wray-Jones EM, Soosay Raj TA, Hanna DMT (2024) Central venous access device adverse events in pediatric patients with cancer: a systematic review and meta-analysis. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-024-08853-0","journal-title":"Support Care Cancer"},{"issue":"10","key":"7010_CR35","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa044097","volume":"353","author":"G Bucaneve","year":"2005","unstructured":"Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D\u2019Antonio D et al (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353(10):977\u2013987. https:\/\/doi.org\/10.1056\/NEJMoa044097","journal-title":"N Engl J Med"},{"key":"7010_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01754-0","volume":"21","author":"D Binyamin","year":"2021","unstructured":"Binyamin D, Nitzan O, Azrad M, Hamo Z, Koren O, Peretz A (2021) The microbial diversity following antibiotic treatment of Clostridioides difficile infection. BMC Gastroenterol 21. https:\/\/doi.org\/10.1186\/s12876-021-01754-0","journal-title":"BMC Gastroenterol"},{"key":"7010_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhin.2023.03.003","volume":"136","author":"M Yang","year":"2023","unstructured":"Yang M, Lu X, Xin L, Luo J, Diao S, Jia Z, Cheng G, Zeng L, Zhang L (2023) Comparative effectiveness and safety of antibiotic prophylaxis during induction chemotherapy in children with acute leukaemia: a systematic review and meta-analysis. J Hosp Infect 136:20\u201329. https:\/\/doi.org\/10.1016\/j.jhin.2023.03.003","journal-title":"J Hosp Infect"},{"issue":"9","key":"7010_CR38","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1093\/jac\/dkr253","volume":"66","author":"MJ Talpaert","year":"2011","unstructured":"Talpaert MJ, Rao GG, Cooper BS, Wade P (2011) Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 66(9):2168\u20132174. https:\/\/doi.org\/10.1093\/jac\/dkr253","journal-title":"J Antimicrob Chemother"},{"key":"7010_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/IDR.S133333","volume":"10","author":"Y Chong","year":"2017","unstructured":"Chong Y, Shimoda S, Miyake N, Aoki T, Ito Y, Kamimura T, Shimono N (2017) Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis. Infect Drug Resist 10:193\u2013199. https:\/\/doi.org\/10.2147\/IDR.S133333","journal-title":"Infect Drug Resist"},{"issue":"SUPPL-4","key":"7010_CR40","doi-asserted-by":"publisher","first-page":"S534","DOI":"10.51253\/pafmj.v75iSUPPL-4.7011","volume":"75","author":"S Naz","year":"2025","unstructured":"Naz S, Tahir M, Arshed A, Ghafoor T, Javed S, Nisa NU (2025) Comparison of outcome of induction chemotherapy in pediatric acute lymphoblastic leukemia between standard risk and high risk group. Pak Armed Forces Med J 75(SUPPL-4):S534\u2013S537. https:\/\/doi.org\/10.51253\/pafmj.v75iSUPPL-4.7011","journal-title":"Pak Armed Forces Med J"},{"key":"7010_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2025.108120","volume":"158","author":"D Unal","year":"2025","unstructured":"Unal D, Gumruk F, Aytac S, Kuskonmaz B, Aksu MD, Okur FV et al (2025) Infectious complications in pediatric acute lymphoblastic leukemia treatment: a comparison of ALL-IC BFM 2009 vs. modified St. Jude total XV in a single-center retrospective cohort study. Leuk Res 158. https:\/\/doi.org\/10.1016\/j.leukres.2025.108120","journal-title":"Leuk Res"},{"issue":"10","key":"7010_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26535","volume":"64","author":"M-J Li","year":"2017","unstructured":"Li M-J, Chang H-H, Yang Y-L, Lu M-Y, Shao P-L, Fu C-M, Chou A-K, Liu Y-L, Lin K-H, Huang L-M (2017) Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: a 16-year tertiary single-institution experience. Pediatr Blood Cancer 64(10). https:\/\/doi.org\/10.1002\/pbc.26535","journal-title":"Pediatr Blood Cancer"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07010-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07010-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07010-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:02:24Z","timestamp":1780120944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07010-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["7010"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07010-5","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}